Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Formation of the Platelet Plug

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

Aortic Regurgitation III: Medical Management

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Physically validated mitral valve models for surgical simulation: Bridging anatomy, pathology, and practice.

JTCVS open·2026

Same author

UNICORN for Native Transcatheter Aortic Valve Replacement in a Bicuspid Aortic Valve.

JACC. Cardiovascular interventions·2026

Same author

Mitral reoperations, reimagined.

JTCVS structural and endovascular·2026

Same author

Mitral valve repair after failed transcatheter edge-to-edge repair: Approach and strategies for success.

JTCVS techniques·2026

Same author

Sex-Related Outcome After Sutureless Aortic Valve Replacement With Perceval Plus: Results From a Global Registry and Meta-Regression.

Interdisciplinary cardiovascular and thoracic surgery·2026

Same author

Impact of Transcatheter Tricuspid Valve Replacement on Liver and Kidney Function in a Real-World Population.

JACC. Heart failure·2026

Search research articles

Related Experiment Video

Updated: May 25, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Platelet reduction after stentless pericardial aortic valve replacement.

Alberto Repossini¹, Daniel Bloch, Claudio Muneretto

¹Department of Cardiac Surgery, University of Brescia, Brescia, Italy. arepossini@yahoo.it

Interactive Cardiovascular and Thoracic Surgery

|January 27, 2012

Summary

Postoperative thrombocytopenia after aortic valve replacement (AVR) with the freedom SOLO (FS) bioprosthesis is a transient issue. Platelet counts typically recover within days, showing no significant clinical consequences.

More Related Videos

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Related Experiment Videos

Last Updated: May 25, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement

Published on: December 11, 2017

Area of Science:

Cardiovascular Surgery
Hematology
Biomaterials Science

Background:

Thrombocytopenia can occur post-aortic valve replacement (AVR).
The freedom SOLO (FS) bioprosthesis is used in AVR procedures.
Understanding postoperative platelet dynamics is crucial for patient management.

Purpose of the Study:

To investigate postoperative thrombocytopenia following AVR with the FS bioprosthesis.
To identify factors associated with thrombocytopenia after FS bioprosthesis implantation.
To assess the clinical implications of postoperative thrombocytopenia.

Main Methods:

A cohort of 254 patients undergoing AVR with FS bioprosthesis was studied.
Platelet counts were monitored preoperatively and daily up to 11 days postoperatively.
A multivariate generalized estimating equation model identified prognostic factors for thrombocytopenia.

Main Results:

11.2% of patients had preoperative thrombocytopenia.
Postoperative platelet counts decreased, reaching a minimum 3 days after surgery.
Platelet counts began to increase by Day 11, with no reported major bleeding or thromboembolic events.

Conclusions:

Thrombocytopenia after FS bioprosthesis replacement is a transient postoperative event.
Platelet counts largely resolve within days, without clinical consequences.
The FS bioprosthesis is associated with temporary, clinically insignificant thrombocytopenia.